IRBM is a scientific contract research organization (CRO) that stands at the forefront of drug discovery, leveraging a single, unified research facility to accelerate team-based breakthroughs and improve efficiencies from concept to candidate.
With a history of contributing to several approved drugs, and its own internal pipeline of oncology and other therapeutic assets, IRBM is powered by deep collaborations and decades of expertise from leading global institutions. Their comprehensive in-house capabilities assist partners in achieving key milestones and progressing towards clinical readiness, positioning IRBM as a major player in driving innovation in the pharmaceutical and biotech fields.
Find more detailed information available on our website below.
Company Details
- Employees
- 292
- Founded
- -
- Address
- Via Pontina Km. 30.600, Pomezia,rome 00071,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- irbm.it
- Keywords
- Drug Discovery, DMPK, Peptide Chemistry, Medicinal Chemistry, Assay Development, High-Throughput Screening, Preclinical Research, Pharmacology, Biochemistry, NMR, Infectious Diseases, Neurodegeneration, Oncology.
- HQ
- Pomezia, Rome
Irbm Questions
Irbm's website is irbm.it
Irbm's LinkedIn profile is https://it.linkedin.com/company/irbm
Irbm has
292 employees.
View email and phone details for 292
employees at Irbm.
Irbm's industry is
Biotechnology Research
Irbm's top competitors are
Biorep,
Takis,
Bsp Pharmaceuticals S.p.a.,
Biogem Istituto Di Biologia E Genetica Molecolare,
Menarini Group,
Generon S.p.a.,
Angelini Pharma,
Alfasigma,
Nouscom,
Reithera.
Irbm's categories are Biotechnology Research
Irbm's founding year is 2009
